ClinicalTrials.Veeva

Menu

Evaluation of Fructose Ingestion and the Renin Angiotensin System in Humans

U

University of Calgary

Status

Completed

Conditions

Chronic Kidney Disease

Treatments

Dietary Supplement: Fructose

Study type

Interventional

Funder types

Other

Identifiers

NCT01407627
AIHS (Other Grant/Funding Number)
UCalgary Sugar Study
University of Calgary (Other Grant/Funding Number)

Details and patient eligibility

About

Fructose is an ingredient that is added to many of our foods. It is a cheaper, sweeter additive that can be found in everything from soda pop to yogurt to granola bars. In the last few years a significant number of studies have been published linking consumption of fructose with obesity, hypertension and more recently, kidney and cardiovascular disease.

Animal studies show a strong link between excessive ingestion of fructose and the development of kidney and cardiovascular disease mediated by the renin angiotensin system, a hormonal system whose activation is detrimental to both the kidney and the heart. There has been very little research done on the potentially pathophysiological relationship between a high fructose diet and kidney and cardiovascular disease in humans.

The investigators hypothesize that ingestion of fructose will result in upregulation of the renin angiotensin system in humans.

Cardiovascular disease in women is a significant risk factor. By having women participate who are on the birth control pill and as well as women who use non oral forms of birth control or no birth control, kidney function and cardiovascular health can be examined as it relates to in the influence oral hormones might play. How the kidney responds to the influence of sugar and fructose while a woman is on an oral birth control pill, may reveal mechanisms that could help us understand cardiovascular disease in women.

Full description

PRIMARY AIM: To examine whether the physiologic and molecular responses to Angiotensin II (AngII) challenge differ in response to fructose intake as assessed by two independent means:

  1. The renal and mean arterial pressure (MAP) response to an AngII challenge.
  2. Reactive changes in circulating levels of renin and aldosterone with graded AngII challenge.

PRIMARY HYPOTHESES: Ingestion of fructose in healthy subjects will result in:

  1. A decrease in renal and systemic sensitivity to infused AngII.
  2. A decrease in the reactive changes in renin and aldosterone with graded AngII challenge.

Enrollment

64 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age≥18 years,
  • able to comprehend study and comply with high-salt diet
  • kidney disease (on the approval of their nephrologist)
  • on an oral birth control pill and non oral birth control and those not on birth control

Exclusion criteria

  • cardiovascular disease (symptoms consistent with myocardial ischemia, previously documented myocardial ischemia, cardiac arrhythmias or valve abnormalities, or abnormal ECG at screening)
  • cerebrovascular disease (transient ischemic attacks or stroke)
  • hypertension (BP>140/90 or use of antihypertensive medications)
  • diabetes mellitus (defined by history, use of hypoglycemic agents or a fasting glucose >7mmol/L)
  • hyperlipidemia (LDL >4.5mmol/L or use of lipid-lowering agents)
  • pregnancy

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

64 participants in 2 patient groups

Fructose First
Experimental group
Description:
1. Study Day 1 - measurement of renal hemodynamics and blood pressure 2. Subjects will ingest fructose 200g daily x 14d 3. Study Day 2 - measurement of renal hemodynamics 4. Minimum 1 week "washout" period 5. Subjects will ingest dextrose 200g daily x 14d 6. Study Day 3 - measurement of renal hemodynamics and blood pressure
Treatment:
Dietary Supplement: Fructose
Dextrose First
Active Comparator group
Description:
1. Study Day 1 - measurement of renal hemodynamics and blood pressure 2. Subjects will ingest dextrose 200g daily x 14d 3. Study Day 2 - measurement of renal hemodynamics 4. Minimum 1 week "washout" period 5. Subjects will ingest fructose 200g daily x 14d 6. Study Day 3 - measurement of renal hemodynamics and blood pressure
Treatment:
Dietary Supplement: Fructose

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems